Search form

For use with Sofia 2 and Sofia - FDA Emergency Use Authorization

The Sofia SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2. The Sofia SARS Antigen FIA, with the Sofia 2 and Sofia analyzers, provides automated and objective results in 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments.

Healthcare professionals can purchase the Sofia SARS Antigen FIA through select authorized distributors.

Features & Benefits

FeatureBenefit

Results in 15 minutes

Rapid results to support efficient dispositioning of patients.

Objective, accurate results

Reliable results without cross-reactivity to seasonal coronaviruses.

Dual work modes

Adjusts to your volume fluctuations. Allows for significant throughput and batching of samples in READ NOW Mode.

Easy to use

Simple test workflow follows a similar format to CLIA-waived Sofia and Sofia 2 assays.

Virena connection

Provides automated tracking, data capture, government reporting, and exclusive disease mapping.

Fluorescent technology with automated read

Objective result that eliminates the subjectivity of a visual read.

All necessary components included in kit

Ready for use with Sofia 2 and Sofia for nasal swab procedure.

Self-contained Test Cassette

Clean, easy to use and dispose of.

Product Specifications

Product Spec NameProduct Spec Data
Time to results

15 minutes

Sample Type

Direct or VTM: Nasal swab, nasopharyngeal swab

Kit storage conditions

Room temperature (15°C to 35°C / 59°F to 86°F)

Controls

Positive and negative, included in kit

PPA

87.5

NPA

100%

CLIA complexity

Moderate complexity*

*Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

Ordering Information

Catalog NumberDescriptionKit Size / Case Size
20374

Test Kit

25/12
Accept
By continuing to use this site you are agreeing to our use of cookies. For more details please see our Privacy and Cookie Notice.